Genetics firm weaves history and DNA for predicting diseases
A company that advises on future health conditions by reading genetic code claims to have shed light on the tricky question of whether family history or genetics predicts disease. Squaring the two has...
View Article23andMe teams up with scientists to make discovery about Parkinson’s
23andMe, the Google-backed genetic testing startup in Mountain View, has once again helped make a discovery about Parkinson’s disease. In a paper published this week in the scientific journal Nature...
View Article23andMe teams with Pfizer to study inflammatory bowel disease
Genetics-testing startup 23andMe said Tuesday it is teaming up with pharmaceutical giant Pfizer to study the genetics of inflammatory bowel disease, or the chronic inflammation of the digestive tract....
View Article23andMe’s health DNA kits now for sale in U.K., still blocked in U.S.
A little more than a year ago, 23andMe, the Google-backed startup that sells mail-order DNA-testing kits, was ordered by U.S. regulators to stop telling consumers about their genetic health risks. The...
View Article23andMe and Genentech target Parkinson’s in deal up to $60 million
Personal genetics-testing startup 23andMe is teaming up with Genentech to try to identify new treatments for Parkinson’s disease, the companies announced Tuesday in the first of several deals 23andMe...
View Article23andMe once again opens up patient data, this time to Pfizer
For the second time in as many weeks, the DNA-testing startup 23andMe is opening its vast warehouse of customers’ genetic data to a major pharmaceutical company, this time Pfizer. Pfizer said Monday...
View ArticleYour genes may be to blame for your motion sickness, 23andMe says
If you’re prone to nausea while riding a car or a roller coaster, your genetics may be responsible, according to a new study from 23andMe. In research published this month, the Mountain View personal...
View Article
